Although this miRNA has not been described in the context of ovarian cancer, its direct targeting of EGFR [55] is an interesting feature, as EGFR downregulation in ovarian cancer cells is known to lead to BIM upregulation and therefore increased apoptosis [56]. This evidence concerns the gene BCL2L11 and ovarian cancer.